Allogene Therapeutics
Clinical trials sponsored by Allogene Therapeutics, explained in plain language.
-
New CAR t therapy aims to wipe out hidden lymphoma cells
Disease control Recruiting nowThis study tests a new treatment called cemacabtagene ansegedleucel (cema-cel) for adults with large B-cell lymphoma who have tiny amounts of cancer left after their first treatment. Participants are randomly assigned to receive either cema-cel (a type of CAR T cell therapy made …
Phase: PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
Engineered immune cells take on autoimmune diseases in first human trial
Disease control Recruiting nowThis early-stage study tests a new treatment called ALLO-329 for people with lupus, myositis, or scleroderma. The therapy uses specially engineered immune cells from a healthy donor to target and calm overactive immune cells. The main goal is to check safety and find the right do…
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:09 UTC